Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID ‐19: a propensity score‐matched analysis

(2021) Matthew L. Meizlish et al.   AMERICAN JOURNAL OF HEMATOLOGY

Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study

(2021) Dario Pellegrini et al.   CIRCULATION

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

(2021) Francesco Santoro et al.   CRITICAL CARE MEDICINE

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

(2020) Haibo Zhang et al.   INTENSIVE CARE MEDICINE

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

(2020) Dominic Wichmann et al.   ANNALS OF INTERNAL MEDICINE

Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19

(2020) Xin Zhou et al.   CIRCULATION

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

(2020) Waleed Alhazzani et al.   CRITICAL CARE MEDICINE

Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae

(2020) Hau C. Kwaan   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Drug treatments for covid-19: living systematic review and network meta-analysis

(2020) Reed AC Siemieniuk et al.   BMJ-British Medical Journal

Coagulation abnormalities and thrombosis in patients with COVID-19

(2020) Marcel Levi et al.   Lancet Haematology

Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19

(2020) Jonathan H. Chow et al.   ANESTHESIA AND ANALGESIA

Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-

(2020) Cosmo Godino et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

(2020) Si Zhang et al.   Journal of Hematology & Oncology

COVID-19 Associated Hypercoagulability

(2020) Michael A. Mazzeffi et al.   SHOCK

Thrombocytopenia and thrombosis in hospitalized patients with COVID-19

(2020) Heng Mei et al.   Journal of Hematology & Oncology

Platelet Activation and Aggregation Promote Lung Inflammation and Influenza Virus Pathogenesis

(2015) Vuong Ba Lê et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Aspirin Attenuates Platelet Activation and Immune Activation in HIV-1-Infected Subjects on Antiretroviral Therapy

(2013) Meagan O’Brien et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES